Immuno-Oncology Drugs Global Market Report 2023
February 13, 2023 15:21 ET
|
ReportLinker
New York, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Immuno-Oncology Drugs Global Market Report 2023" -...
2028 Immuno-Oncology Market Report Puts Limelight on Market Size, Share, Growth Opportunities, Factors and Trends Influencing the Industry | Xcellent Insights
February 07, 2023 09:20 ET
|
XCELLENT INSIGHTS LLP
Pune, Feb. 07, 2023 (GLOBE NEWSWIRE) -- The global Immuno-Oncology Market Size was USD 43698.02 million in 2021 and is expected to register a robust revenue CAGR of 15.05% during the forecast...
The Global Head And Neck Cancer Therapeutics Market size is expected to reach $2.5 billion by 2028, rising at a market growth of 12.3% CAGR during the forecast period
December 20, 2022 13:37 ET
|
ReportLinker
New York, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By...
Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of Directors
September 26, 2022 08:00 ET
|
Phathom Pharmaceuticals
FLORHAM PARK, N.J., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...
Nkarta Announces Key Senior Leadership Team Appointments
July 25, 2022 16:31 ET
|
Nkarta, Inc.
Ralph Brandenberger, PhD, promoted to Chief Technical OfficerYvonne Li, MBA, promoted to Chief Administrative OfficerEvolution of Nkarta leadership team to support rapid development of allogeneic,...
Community Oncology Services Market Players Are Implementing New Technologies To Improve Treatment Efficiency As Per The Business Research Company's Community Oncology Services Global Market Report 2022
May 24, 2022 11:30 ET
|
TBRC Business Research PVT LTD
LONDON, May 24, 2022 (GLOBE NEWSWIRE) -- According to The Business Research Company’s research report on the community oncology services market, the adoption of new technology to achieve complete or...
Press Release: Sanofi continues to deliver strong business EPS growth driven by higher sales and improved margins in Q1
April 28, 2022 01:30 ET
|
Sanofi - Aventis Groupe
Sanofi continues to deliver strong business EPS(1) growth driven by higher sales and improved margins in Q1 Paris, April 28, 2022 Q1 2022 sales growth of 8.6% at CER driven by...
Press Release: Sanofi continues to deliver strong business EPS growth driven by higher sales and improved margins in Q1
April 28, 2022 01:30 ET
|
Sanofi - Aventis Groupe
Sanofi continues to deliver strong business EPS(1) growth driven by higher sales and improved margins in Q1 Paris, April 28, 2022 Q1 2022 sales growth of 8.6% at CER driven by Dupixent® and CHC...
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update
March 21, 2022 16:00 ET
|
ORIC Pharmaceuticals
Announces decision to discontinue development of ORIC-101 Company will focus on advancing its three single agent Phase 1 programs, ORIC-533 in multiple myeloma, ORIC-114 in EGFR/HER2 cancers, and...
Efanesoctocog alfa met primary and key secondary endpoints in pivotal study in hemophilia A, demonstrating superiority to prior factor prophylaxis treatment
March 09, 2022 01:00 ET
|
Sanofi - Aventis Groupe
Efanesoctocog alfa met primary and key secondary endpoints in pivotal study in hemophilia A, demonstrating superiority to prior factor prophylaxis treatment Once-weekly efanesoctocog alfa met primary...